Ondas Grew Revenue 16-Fold. Its Stock Still Fell 69%.
Ondas posted $167.5 million in Q3 revenue, 16 times a year earlier, with $835 million backlog. Yet shares sit 69% below their high as dilution and thin margins bite.
By Grace Kim
3 min read

What's News
- Ondas Q3 revenue hit $167.5 million, more than 16x the year-ago level, with backlog at $835 million.
- Gross margin fell from 43.1% to 21.8% in one quarter as strategic contracts carried the thinnest margins.
- Share count rose more than fivefold in 18 months; cash fell from about $1.4 billion to $820 million in a quarter.
- A $918.6 million warrant liability shrank as the stock fell, generating $125.1 million in paper gains.
- Management targets company-wide adjusted EBITDA breakeven by Q3 2027.
Ondas (Nasdaq: ONDS) posted third-quarter revenue of $167.5 million — more than 16 times the year-ago level — and backlog climbed to $835 million, yet the shares trade roughly 69% below their 52-week high. The gap between the top line and the ticker has little to do with demand. According to an analysis by TradingView contributor UDIS_View, the market now prices Ondas's share count more than its drones.
The company has transformed itself from a small rail-radio business into a multi-domain defense group. That shift came with real geopolitical traction, and real costs.
Where the growth is coming from
The demand signals look concrete. Israel's Ministry of Defense selected Ondas for its "Digital Bat" low-cost attack drone program. The U.S. Army buys lethal unmanned systems through Ondas's Mistral unit. A European loitering munition program ordered $56 million of safety-and-arming devices manufactured in Poland — a structure that sits outside U.S. export rules.
The hires and hardware match the ambition. Former Mossad director David Barnea joined as global president. On the technology side, the ULTRA surveillance aircraft and the IonStrike interceptor, targeted below $50,000 per unit, could reshape the economics of drone defense. One caveat from the source: management itself still makes those cost claims, so the sub-$50,000 figure remains a target, not a delivered price.
Takeaway: the order book is real, and the customer list now spans three continents.
What the numbers underneath show
The less flattering story sits below the headline revenue. Ondas's most strategic contracts carry its thinnest margins, so gross margin fell from 43.1% to 21.8% in a single quarter. That's a halving of profitability on the way to a 16-fold revenue gain — growth that management is effectively buying with margin.
The accounting adds a wrinkle. A $918.6 million warrant liability shrank as the share price fell, producing $125.1 million in paper gains while operations burned cash. So part of the "improved profitability" the title of the source piece points to is a mark-to-market artifact of a falling stock, not operating income.
Even the intellectual property story needs correction. A docking patent credited to Ondas in circulating research actually belongs to Teledyne FLIR, a competitor. Per the analysis, Ondas's real advantage lies in its factories in Israel, Germany and Poland — manufacturing footprint, not patents.
Takeaway: the profit optics improve partly because the stock is falling.
The dilution problem
The share count rose more than fivefold in 18 months as Ondas funded acquisitions. Cash fell from roughly $1.4 billion to $820 million in a single quarter. That combination — more shares, less cash — explains the 69% drawdown better than any demand indicator.
Management has responded with commitments: a slower deal pace and company-wide adjusted EBITDA breakeven by the third quarter of 2027. That date gives investors a concrete checkpoint. If breakeven arrives on schedule, the dilution math changes; if it slips, the fivefold share expansion may not be the ceiling.
Takeaway: this is now a race between contract revenue and share issuance.
What to watch next
For investors, the key question is no longer whether Ondas can win contracts — the $835 million backlog and the Israeli, U.S. and European programs answer that. It is whether those contracts can reward shareholders before dilution consumes the gains. The Q3 2027 EBITDA-breakeven target, gross margin recovery from 21.8%, and the pace of new share issuance are the three numbers to track.
Source: tradingview.com
More from Grace Kim
Show full bio
Market editor covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.
2,206 articles